Kyntra Bio (KYNB) Receivables - Other (2014 - 2026)
Kyntra Bio (KYNB) posted Receivables - Other of $4.0 million for Q1 2026, little changed sequentially from $4.0 million in Q4 2025.
Kyntra Bio (KYNB) Receivables - Other (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Receivables - Other for 13 years, with the latest figure at $4.0 million in Q1 2026.
- Quarterly Receivables - Other changed N/A year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.0 million, down 85.96% from the prior year.
- Receivables - Other was little changed at $4.0 million in Q1 2026 per KYNB's latest filing, from $4.0 million in the prior quarter.
- Over five years, Receivables - Other peaked at $38.8 million in Q1 2022 and troughed at $4.0 million in Q3 2023.
- A 5-year average of $19.9 million and a median of $23.4 million in 2022 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 612.5% in 2024, then slumped 85.96% in 2025.
- Over 5 years, Receivables - Other stood at $12.1 million in 2022, then surged by 135.77% to $28.5 million in 2023, then changed by 0.0% to $28.5 million in 2024, then plunged by 85.96% to $4.0 million in 2025, then changed by 0.0% to $4.0 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $4.0 million, $4.0 million, and $28.5 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Kyntra Bio | 29.63 Mn | 29.63 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 28.50 Mn |
| Dec 31, 2024 | 28.50 Mn |
| Sep 30, 2024 | 28.50 Mn |
| Sep 30, 2024 | 28.50 Mn |
| Jun 30, 2024 | 28.50 Mn |
| Jun 30, 2024 | 28.50 Mn |
| Mar 31, 2024 | 28.50 Mn |
| Mar 31, 2024 | 28.50 Mn |
| Dec 31, 2023 | 28.50 Mn |
| Dec 31, 2023 | 28.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Mar 31, 2023 | 11.56 Mn |
| Mar 31, 2023 | 11.56 Mn |